Team:UGent/Ethics/Prof dr Geert De Jaeger
From 2013.igem.org
Line 3: | Line 3: | ||
<html> | <html> | ||
<h1>Prof. dr. Geert De Jaeger</h1> | <h1>Prof. dr. Geert De Jaeger</h1> | ||
- | |||
<img src="https://static.igem.org/mediawiki/2013/f/fb/UGent_2013_Prof_dr_Geert_De_Jaeger.jpg" align="left" width="170" hspace="20"> | <img src="https://static.igem.org/mediawiki/2013/f/fb/UGent_2013_Prof_dr_Geert_De_Jaeger.jpg" align="left" width="170" hspace="20"> | ||
<p class="font"> | <p class="font"> |
Latest revision as of 21:54, 3 October 2013
Prof. dr. Geert De JaegerGeert De Jaeger is professor at the University of Ghent and teaches Plant Biotechnology and Biotechnology and Society. He is Deputy Department Director of the Department of Plant System Biology at the VIB (Flemish Institute for Biotechnology) in Ghent. His lab focusses on the study of interactomics in plants. Their long term goal is to map the gene networks involved in cell proliferation by system wide interactomic approaches such as protein and chromatin complex isolation.
‘Synthetic biology’ is not well-defined and it is not very clear which topics pertain to this branch of science. ‘The synthesis of living systems’ is the narrow definition of synthetic biology. It all started with Craig Venter, who transferred a synthetic chromosome from one mycoplasma to another, and thereby claimed to have created life. This in fact wasn’t true, because properties were transferred into an already existing cell. More broadly the term includes the creation of functional biobricks which can be used to alter the features of a living creature. But then what is the difference with genetic engineering? Part of synthetic biology probably can be seen as a more sophisticated form of genetic engineering.
To discuss the purpose and the utility of patents, it is important to make a distinction between creating new software and making new entities in the lab. Much higher costs are associated with the latter. Wanting to gain credit for something you created, having put a lot of resources in it, is an automatic reflex. If society would abolish patents, there could rise a tendency to stop investing in such projects as they are no longer lucrative. However, it is an interesting view to prohibit patents in synthetic biology in order to stimulate the development of new systems. That is why a probable solution could be to release the building blocks to open source, but to permit patents on finished products. Investors would still invest and development will not be counteracted.
|
Tweets van @iGEM_UGent |
|